Silo Pharma, Inc. (SILO) vs Beyond Air, Inc. (XAIR)
A side-by-side comparison of Silo Pharma, Inc. and Beyond Air, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SILO
Silo Pharma, Inc.
$1.45HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
XAIR
Beyond Air, Inc.
$2.55HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — SILO vs XAIR
growth of $100 · dividends reinvested · last 6ySILO -99.4% (-57.8%/yr)XAIR -99.9% (-67.4%/yr)SILO compounded faster over this window
SILO XAIR
SILO vs XAIR: by the numbers
- •XAIR is the larger company ($2M vs $2M market cap).
- •Both run net losses; XAIR's is the smaller (-435.71% vs -8269.53% net margin).
- •XAIR grew revenue faster over the past five years (64.21% vs 0.29% CAGR).
Metrics side by side
Valuation
| Metric | SILO | XAIR |
|---|---|---|
| P/S ratio | 30.26 | 0.24 |
| P/B ratio | 0.33 | N/A |
Profitability
| Metric | SILO | XAIR |
|---|---|---|
| Gross margin | -1128.89% | 4.18% |
| Operating margin | -5936.95% | -378.23% |
| Net margin | -8269.53% | -435.71% |
| ROE | -91.52% | -1677.17% |
| ROIC | -91.31% | -106.06% |
Growth (annualized)
| Metric | SILO | XAIR |
|---|---|---|
| Revenue CAGR (5Y) | 0.29% | 64.21% |
| Total return CAGR (5Y) | -61.41% | -76.73% |
Frequently asked
- Which has grown faster, SILO or XAIR?
- Over the past five years, XAIR grew revenue faster — SILO at a 0.29% CAGR versus XAIR at 64.21%.
- How have SILO and XAIR total returns compared?
- Over the past 5 years, SILO delivered -61.41% and XAIR delivered -76.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Silo Pharma ROEBeyond Air ROESilo Pharma operating marginBeyond Air operating marginSilo Pharma revenue growthBeyond Air revenue growthSilo Pharma free cash flowBeyond Air free cash flow
Silo Pharma & Beyond Air appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.